{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:39:20Z","timestamp":1754483960954},"reference-count":197,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780323855631"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/b978-0-323-85563-1.00011-3","type":"book-chapter","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T14:05:16Z","timestamp":1627049116000},"page":"217-258","source":"Crossref","is-referenced-by-count":2,"title":["Updated perspective and directions on hereditary diffuse gastric cancer"],"prefix":"10.1016","author":[{"given":"Irene","family":"Gullo","sequence":"first","affiliation":[]},{"given":"Carla","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Rachel S.","family":"van der Post","sequence":"additional","affiliation":[]},{"given":"Jolanda M.","family":"van Dieren","sequence":"additional","affiliation":[]},{"given":"Jeremy L.","family":"Davis","sequence":"additional","affiliation":[]},{"given":"Nicola","family":"Bougen-Zhukov","sequence":"additional","affiliation":[]},{"given":"Parry","family":"Guilford","sequence":"additional","affiliation":[]},{"given":"F\u00e1tima","family":"Carneiro","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0001","article-title":"Global Cancer Observatory: Cancer Today","author":"Ferlay","year":"2020","journal-title":"Int. Agency Res. Cancer"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0002","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1016\/S1470-2045(14)71016-2","article-title":"Familial gastric cancer: genetic susceptibility, pathology, and implications for management","volume":"16","author":"Oliveira","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0003","series-title":"Digestive System Tumours","first-page":"511","article-title":"Genetic Tumour Syndromes of the Digestive System","year":"2019"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0004","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/his.14228","article-title":"Recent advances in the pathology of heritable cancer syndromes","volume":"78","author":"Gullo","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0005","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/32918","article-title":"E-cadherin germline mutations in familial gastric cancer","volume":"392","author":"Guilford","year":"1998","journal-title":"Nature"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0006","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0002-9440(10)65129-2","article-title":"Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation","volume":"155","author":"Keller","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0007","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO;2-9","article-title":"E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer","volume":"14","author":"Guilford","year":"1999","journal-title":"Hum. Mutat."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0008","first-page":"4086","article-title":"Identification of germ-line E-cadherin mutations in gastric cancer families of European origin","volume":"58","author":"Gayther","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0009","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/hmg\/8.4.607","article-title":"Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer","volume":"8","author":"Richards","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0010","first-page":"873","article-title":"Familial gastric cancer: overview and guidelines for management","volume":"36","author":"Caldas","year":"1999","journal-title":"J. Med. Genet."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0011","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","article-title":"The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification","volume":"64","author":"Lauren","year":"1965","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0012","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/jmg.2009.074237","article-title":"Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research","volume":"47","author":"Fitzgerald","year":"2010","journal-title":"J. Med. Genet."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0013","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/jmedgenet-2015-103094","article-title":"Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers","volume":"52","author":"Van der Post","year":"2015","journal-title":"J. Med. Genet."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0014","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1016\/S1470-2045(20)30219-9","article-title":"Hereditary diffuse gastric cancer: updated clinical practice guidelines","volume":"21","author":"Blair VR","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","article-title":"Hereditary diffuse gastric cancer syndrome CDH1 mutations and beyond","volume":"1","author":"Hansford","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0016","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/jmedgenet-2018-105361","article-title":"Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC)","volume":"56","author":"Lo","year":"2019","journal-title":"J. Med. Genet."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0017","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/annonc\/mdg486","article-title":"The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice","volume":"14","author":"Graziano","year":"2003","journal-title":"Ann. Oncol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0018","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1007\/s00018-008-8281-1","article-title":"The cell-cell adhesion molecule E-cadherin","volume":"65","author":"van Roy","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0019","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/path.1564","article-title":"Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening","volume":"203","author":"Carneiro","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/jmedgenet-2018-105807","article-title":"Clinical spectrum and pleiotropic nature of CDH1 germline mutations","volume":"56","author":"Figueiredo","year":"2019","journal-title":"J. Med. Genet."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0021","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/jmg.2005.031385","article-title":"Cleft lip\/palate and CDH1\/E-cadherin mutations in families with hereditary diffuse gastric cancer","volume":"43","author":"Frebourg","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0022","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/hmg\/dds497","article-title":"Identification of germline mutations in the cancer predisposing gene CDH1 in patients with orofacial clefts","volume":"22","author":"Vogelaar","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0023","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/humu.22827","article-title":"Rare variants in the epithelial cadherin gene underlying the genetic etiology of nonsyndromic cleft lip with or without cleft palate","volume":"36","author":"Brito","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0024","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10689-018-0111-5","article-title":"Cleft lip\/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687\u2009+\u20091G\u2009>\u2009A germline mutation and review of the literature","volume":"18","author":"Obermair","year":"2019","journal-title":"Fam. Cancer"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0025","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/jmedgenet-2015-103153","article-title":"Hereditary diffuse gastric cancer syndrome: improved performances of the 2015 testing criteria for the identification of probands with a CDH1 germline mutation","volume":"52","author":"Benusiglio","year":"2015","journal-title":"J. Med. Genet."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0026","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/path.4152","article-title":"An alpha-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer","volume":"229","author":"Majewski","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0027","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/jmedgenet-2017-104962","article-title":"Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility","volume":"55","author":"Weren","year":"2018","journal-title":"J. Med. Genet."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0028","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41436-020-0753-1","article-title":"Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancer","volume":"22","author":"Clark","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0029","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1001\/jama.297.21.2360","article-title":"Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer","volume":"297","author":"Kaurah","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0030","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.gie.2018.02.008","article-title":"Phenotypic heterogeneity of hereditary diffuse gastric cancer: report of a family with early-onset disease","volume":"87","author":"Gullo","year":"2018","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0031","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/jmedgenet-2015-103094","article-title":"Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers","volume":"52","author":"van der Post","year":"2015","journal-title":"J. Med. Genet."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0032","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-med-051019-103216","article-title":"Hereditary diffuse gastric cancer: approaches to screening, surveillance, and treatment","volume":"72","author":"Pilonis","year":"2020","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0033","doi-asserted-by":"crossref","first-page":"407","DOI":"10.21037\/jgo.2019.01.04","article-title":"Evaluation of confocal endoscopic microscopy for detection of early-stage gastric cancer in hereditary diffuse gastric cancer (HDGC) syndrome","volume":"10","author":"Ruff","year":"2019","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0034","article-title":"Evaluation of confocal laser endomicroscopy for detection of occult gastric carcinoma in CDH1 Variant carriers","author":"Schueler","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0035","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1055\/a-1157-8678","article-title":"Gastroscopic surveillance with targeted biopsies compared with random biopsies in CDH1 mutation carriers","volume":"52","author":"van Dieren","year":"2020","journal-title":"Endoscopy"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0036","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jamaoncol.2019.1208","article-title":"Comparison of CDH1 penetrance estimates in clinically ascertained families vs families ascertained for multiple gastric cancers","volume":"5","author":"Roberts","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0037","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/jmedgenet-2019-105991","article-title":"Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria","volume":"56","author":"Xicola","year":"2019","journal-title":"J. Med. Genet."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0038","doi-asserted-by":"crossref","first-page":"eaav9778","DOI":"10.1126\/sciadv.aav9778","article-title":"Defined lifestyle and germline factors predispose Asian populations to gastric cancer","volume":"6","author":"Suzuki","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0039","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/jmedgenet-2012-101472","article-title":"CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study","volume":"50","author":"Benusiglio","year":"2013","journal-title":"J. Med. Genet."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0040","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1002\/cncr.25876","article-title":"Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer","volume":"117","author":"Xie","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0041","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/jmedgenet-2018-105337","article-title":"Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect","volume":"55","author":"Corso","year":"2018","journal-title":"J. Med. Genet."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0042","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PAS.0b013e31815e7f1a","article-title":"Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications","volume":"32","author":"Rogers","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0043","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/PAS.0000000000001511","article-title":"Histopathologic analysis of signet-ring cell carcinoma in situ in patients with hereditary diffuse gastric cancer","volume":"44","author":"Tsugeno","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0044","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/his.13715","article-title":"Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management","volume":"73","author":"Rocha","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/156652407779940503","article-title":"Early onset gastric cancer: on the road to unraveling gastric carcinogenesis","volume":"7","author":"Milne","year":"2007","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0046","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1158\/0008-5472.CAN-06-3021","article-title":"Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer","volume":"67","author":"Humar","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0047","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029330","article-title":"Loss of E-Cadherin-dependent cell-cell adhesion and the development and progression of cancer","volume":"10","author":"Bruner","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0048","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00712735","article-title":"Cell proliferation and differentiation in intramucosal and advanced signet ring cell carcinomas of the human stomach","volume":"411","author":"Sugihara","year":"1987","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0049","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0344-0338(87)80066-3","article-title":"Characterization of four main cell types in gastric cancer: foveolar, mucopeptic, intestinal columnar and goblet cells. An histopathologic, histochemical and ultrastructural study of \u201cearly\u201d and \u201cadvanced\u201d tumours","volume":"182","author":"Fiocca","year":"1987","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.humpath.2017.12.023","article-title":"Histologic and immunohistochemical differences between hereditary and sporadic diffuse gastric carcinoma","volume":"74","author":"Lee","year":"2018","journal-title":"Hum. Pathol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0051","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s12253-018-0547-9","article-title":"Early hereditary diffuse gastric cancer (eHDGC) is characterized by subtle genomic instability and active DNA damage response","volume":"25","author":"Nasri","year":"2019","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0052","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/978-3-319-41388-4_18","article-title":"Histopathological, molecular, and genetic profile of hereditary diffuse gastric cancer: current knowledge and challenges for the future","volume":"908","author":"van der Post","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0053","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1053\/j.gastro.2009.02.065","article-title":"Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression","volume":"136","author":"Oliveira","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0054","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1200\/JCO.2012.44.4612","article-title":"Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer","volume":"31","author":"Corso","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0055","series-title":"Breast Tumours","first-page":"114","article-title":"Invasive lobular carcinoma","year":"2019"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0056","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ijc.26398","article-title":"CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counseling","volume":"131","author":"Kluijt","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0057","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/PAS.0b013e31826ca204","article-title":"Endoscopic surveillance of patients with hereditary diffuse gastric cancer: biopsy recommendations after topographic distribution of cancer foci in a series of 10 CDH1-mutated gastrectomies","volume":"36","author":"Fujita","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0058","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10689-013-9698-8","article-title":"Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational study","volume":"13","author":"Bardram","year":"2014","journal-title":"Fam. Cancer"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0059","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/path.2415","article-title":"Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk","volume":"216","author":"Barber","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0060","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s10120-018-00912-w","article-title":"Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer","volume":"22","author":"Funakoshi","year":"2019","journal-title":"Gastric. Cancer"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0061","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1056\/NEJM200106213442504","article-title":"Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations","volume":"344","author":"Huntsman","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0062","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/1097-0142(20010701)92:1<181::AID-CNCR1307>3.0.CO;2-J","article-title":"Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated?","volume":"92","author":"Chun","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0063","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.gie.2013.11.040","article-title":"Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance","volume":"80","author":"Lim","year":"2014","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2020.151473","article-title":"Complete histopathologic examination of risk reduction gastrectomy specimens for CDH1 germline mutation: Is it warranted in routine clinical practice?","volume":"45","author":"Zhang","year":"2020","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0065","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/gut.2002.010447","article-title":"Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone","volume":"53","author":"Charlton","year":"2004","journal-title":"Gut"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0066","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cgh.2005.12.003","article-title":"Hereditary diffuse gastric cancer: diagnosis and management","volume":"4","author":"Blair","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0067","doi-asserted-by":"crossref","DOI":"10.4132\/jptm.2020.12.22","article-title":"Deep learning for computer-assisted diagnosis of hereditary diffuse gastric cancer","author":"Rasmussen","year":"2021","journal-title":"J. Pathol. Transl. Med."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0068","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/humu.10068","article-title":"Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred","volume":"19","author":"Oliveira","year":"2002","journal-title":"Hum. Mutat."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0069","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/hmg\/ddp046","article-title":"Germline CDH1 deletions in hereditary diffuse gastric cancer families","volume":"18","author":"Oliveira","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0070","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/hmg\/ddp537","article-title":"Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer","volume":"19","author":"Pinheiro","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0071","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/gcc.22155","article-title":"Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome","volume":"53","author":"Molinaro","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0072","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004669","article-title":"Germline mutations in MAP3K6 are associated with familial gastric cancer","volume":"10","author":"Gaston","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0073","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10689-014-9764-x","article-title":"Gastric cancer in three relatives of a patient with a biallelic IL12RB1 mutation","volume":"14","author":"Vogelaar","year":"2015","journal-title":"Fam. Cancer"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0074","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10689-015-9778-z","article-title":"Exome sequencing reveals three novel candidate predisposition genes for diffuse gastric cancer","volume":"14","author":"Donner","year":"2015","journal-title":"Fam. Cancer"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0075","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S2468-1253(18)30079-7","article-title":"Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study","volume":"3","author":"Fewings","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0076","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1083\/jcb.75.2.464","article-title":"Functional correlation between cell adhesive properties and some cell surface proteins","volume":"75","author":"Takeichi","year":"1977","journal-title":"J. Cell. Biol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0077","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1006\/bbrc.1994.2322","article-title":"The genes for the calcium-dependent cell adhesion molecules P- and E-cadherin are tandemly arranged in the human genome","volume":"203","author":"Bussemakers","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"37","key":"10.1016\/B978-0-323-85563-1.00011-3_bib0078","doi-asserted-by":"crossref","first-page":"D690","DOI":"10.1093\/nar\/gkn828","article-title":"Ensembl","volume":"2009","author":"Hubbard","year":"2009","journal-title":"Nuc. Acids Res."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0079","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1039\/b719215k","article-title":"Cadherins in development and cancer","volume":"4","author":"Stemmler","year":"2008","journal-title":"Mol. Biosyst."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0080","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","article-title":"Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis","volume":"117","author":"Yang","year":"2004","journal-title":"Cell"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0081","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1038\/onc.2010.102","article-title":"ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI\/SNF chromatin-remodeling protein BRG1","volume":"29","author":"S\u00e1nchez-Till\u00f3","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0082","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S1097-2765(01)00260-X","article-title":"The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion","volume":"7","author":"Comijn","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0083","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ncb2024","article-title":"miR-9, a MYC\/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis","volume":"12","author":"Ma","year":"2010","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0084","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12867-018-0107-6","article-title":"Targeting miR-9 in gastric cancer cells using locked nucleic acid oligonucleotides","volume":"19","author":"Lima","year":"2018","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0085","first-page":"3709","article-title":"MicroRNA-572 targets CDH1 to promote metastasis of Wilms\u2019 tumor","volume":"23","author":"Zhang","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0086","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12010-015-1505-6","article-title":"MicroRNA-10b triggers the epithelial-mesenchymal transition (EMT) of laryngeal carcinoma Hep-2 cells by directly targeting the E-cadherin","volume":"176","author":"Zhang","year":"2015","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0087","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1586\/14737159.3.2.201","article-title":"Genetic screening for hereditary diffuse gastric cancer","volume":"3","author":"Oliveira","year":"2003","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0088","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0955-0674(95)80102-2","article-title":"Morphogenetic roles of classic cadherins","volume":"7","author":"Takeichi","year":"1995","journal-title":"Curr. Opin. Cell. Biol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0089","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/374327a0","article-title":"Structural basis of cell-cell adhesion by cadherins","volume":"374","author":"Shapiro","year":"1995","journal-title":"Nature"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0090","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrm1699","article-title":"Regulation of cadherin-mediated adhesion in morphogenesis","volume":"6","author":"Gumbiner","year":"2005","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0091","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1242\/jcs.1993.Supplement_17.22","article-title":"Catenins as mediators of the cytoplasmic functions of cadherins","volume":"17","author":"Gumbiner","year":"1993","journal-title":"J. Cell. Sci."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0092","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ceb.2005.08.009","article-title":"The regulation of cadherin-mediated adhesion by tyrosine phosphorylation\/dephosphorylation of beta-catenin","volume":"17","author":"Lilien","year":"2005","journal-title":"Curr. Opin. Cell. Biol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0093","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0092-8674(01)00330-0","article-title":"The structure of the beta-catenin\/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin","volume":"105","author":"Huber","year":"2001","journal-title":"Cell"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0094","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1073\/pnas.87.11.4246","article-title":"Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule","volume":"87","author":"Ozawa","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0095","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/15419069409014207","article-title":"A short core region of E-cadherin is essential for catenin binding and is highly phosphorylated","volume":"2","author":"Stappert","year":"1994","journal-title":"Cell Adhes. Commun."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0096","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1074\/jbc.275.7.5090","article-title":"Casein kinase II phosphorylation of E-cadherin increases E-cadherin\/beta-catenin interaction and strengthens cell-cell adhesion","volume":"275","author":"Lickert","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0097","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/excr.2000.4895","article-title":"The disruption of adherens junctions is associated with a decrease of E-cadherin phosphorylation by protein kinase CK2","volume":"257","author":"Serres","year":"2000","journal-title":"Exp. Cell Res."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0098","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1074\/jbc.M511338200","article-title":"Thermodynamics of beta-catenin-ligand interactions: the roles of the N- and C-terminal tails in modulating binding affinity","volume":"281","author":"Choi","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0099","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/B978-0-12-394311-8.00015-7","article-title":"E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer","volume":"116","author":"Oliveira","year":"2013","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0100","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1038\/onc.2008.343","article-title":"Cadherins and cancer: how does cadherin dysfunction promote tumor progression?","volume":"27","author":"Jeanes","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0101","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1016\/j.febslet.2012.07.045","article-title":"E-cadherin dysfunction in gastric cancer\u2014cellular consequences, clinical applications and open questions","volume":"586","author":"Carneiro","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0102","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12943-018-0859-0","article-title":"E-cadherin signal sequence disruption: a novel mechanism underlying hereditary cancer","volume":"17","author":"Figueiredo","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0103","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/humu.23650","article-title":"Specifications of the ACMG\/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants","volume":"39","author":"Lee","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0104","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/79120","article-title":"Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer","volume":"26","author":"Grady","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0106","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1038\/sj.onc.1207335","article-title":"Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour","volume":"23","author":"Oliveira","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0107","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ejso.2007.03.001","article-title":"Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management","volume":"33","author":"Corso","year":"2007","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0108","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/path.2426","article-title":"Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer","volume":"216","author":"Barber","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0109","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/path.4032","article-title":"Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer","volume":"228","author":"Carvalho","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0110","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0111","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10689-016-9869-5","article-title":"CDH1 germline mutations and hereditary lobular breast cancer","volume":"15","author":"Corso","year":"2016","journal-title":"Fam. Cancer"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.16.00021","article-title":"Unexpected CDH1 mutations identified on multigene panels pose clinical management challenges","author":"Lowstuter","year":"2017","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0113","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.cell.2005.09.021","article-title":"Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly","volume":"123","author":"Drees","year":"2005","journal-title":"Cell"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0114","doi-asserted-by":"crossref","first-page":"8813","DOI":"10.1073\/pnas.92.19.8813","article-title":"Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex","volume":"92","author":"Rimm","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0115","doi-asserted-by":"crossref","first-page":"27301","DOI":"10.1074\/jbc.272.43.27301","article-title":"Alpha-catenin can form asymmetric homodimeric complexes and\/or heterodimeric complexes with beta-catenin","volume":"272","author":"Koslov","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0116","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0092-8674(01)00246-X","article-title":"Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin","volume":"104","author":"Vasioukhin","year":"2001","journal-title":"Cell"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0117","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s10120-018-00907-7","article-title":"Clinical implications of CTNNA1 germline mutations in asymptomatic carriers","volume":"22","author":"Benusiglio","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0118","series-title":"Digestive System Tumours","first-page":"85","article-title":"Gastric adenocarcinoma","year":"2019"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0119","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.gie.2017.04.016","article-title":"Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria","volume":"87","author":"van der Post","year":"2018","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/gut.2004.049171","article-title":"Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy?","volume":"54","author":"Shaw","year":"2005","journal-title":"Gut"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0121","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1245\/s10434-009-0471-z","article-title":"Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients","volume":"16","author":"Hebbard","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0122","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1245\/s10434-011-1648-9","article-title":"A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer","volume":"18","author":"Chen","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0123","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.surg.2010.07.005","article-title":"Prophylactic total gastrectomy for individuals with germline CDH1 mutation","volume":"149","author":"Pandalai","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0124","doi-asserted-by":"crossref","first-page":"E1305","DOI":"10.1055\/s-0042-112582","article-title":"Chromoendoscopy in combination with random biopsies does not improve detection of gastric cancer foci in CDH1 mutation positive patients","volume":"4","author":"H\u00fcneburg","year":"2016","journal-title":"Endosc. Int. Open"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0125","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.gie.2017.06.028","article-title":"Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status","volume":"87","author":"Mi","year":"2018","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0126","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/j.gastro.2019.03.047","article-title":"Outcomes of endoscopic surveillance in individuals with genetic predisposition to hereditary diffuse gastric cancer","volume":"157","author":"Jacobs","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0127","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cgh.2019.10.033","article-title":"Surveillance endoscopy in the management of hereditary diffuse gastric cancer syndrome","volume":"19","author":"Friedman","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0128","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jamasurg.2020.3356","article-title":"Indications for total gastrectomy in CDH1 mutation carriers and outcomes of risk-reducing minimally invasive and open gastrectomies","volume":"155","author":"Vos","year":"2020","journal-title":"JAMA Surg."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00535-020-01749-w","article-title":"Enhanced endoscopic detection of occult gastric cancer in carriers of pathogenic CDH1 variants","volume":"56","author":"Curtin","year":"2020","journal-title":"J. Gastroenterol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0130","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.gie.2017.06.028","article-title":"Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status","volume":"87","author":"Mi","year":"2018","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0131","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.gie.2009.12.007","article-title":"Confocal laser endomicroscopy in Barrett\u2019s esophagus and endoscopically inapparent Barrett\u2019s neoplasia: a prospective, randomized, double-blind, controlled, crossover trial","volume":"72","author":"Dunbar","year":"2010","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0132","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1055\/s-2006-944735","article-title":"Development and assessment of morphologic criteria for diagnosing gastric cancer using confocal endomicroscopy: an ex vivo and in vivo study","volume":"38","author":"Kakeji","year":"2006","journal-title":"Endoscopy"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0133","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1055\/s-2006-944855","article-title":"Confocal endomicroscopy for the diagnosis of gastric cancer in vivo","volume":"38","author":"Kitabatake","year":"2006","journal-title":"Endoscopy"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0134","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.gie.2009.02.009","article-title":"Confocal laser endomicroscopy in Barrett\u2019s esophagus and endoscopically inapparent Barrett\u2019s neoplasia: a prospective, randomized, double-blind, controlled, crossover trial","volume":"70","author":"Dunbar","year":"2009","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0135","doi-asserted-by":"crossref","DOI":"10.17235\/reed.2020.6720\/2019","article-title":"Random biopsies in patients harboring a CDH1 mutation: time to change the approach?","volume":"112","author":"Castro","year":"2020","journal-title":"Rev. Esp Enferm. Dig."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0136","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0137","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","article-title":"Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk","volume":"33","author":"King","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0138","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-012-2318-8","article-title":"The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions","volume":"136","author":"Coopey","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0139","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2013.49.3122","article-title":"Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline","volume":"31","author":"Visvanathan","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0140","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00042737-200608000-00010","article-title":"Chemoprevention of gastric cancer","volume":"18","author":"Leung","year":"2006","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0141","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/jgh.14646","article-title":"Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism","volume":"34","author":"Kim","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0142","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/bmj.320.7250.1642","article-title":"Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database","volume":"320","author":"Langman","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0143","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/jnci\/djg106","article-title":"Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis","volume":"95","author":"Wang","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0144","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1349-7006.2009.01163.x","article-title":"Hereditary diffuse gastric cancer: a manifestation of lost cell polarity","volume":"100","author":"Humar","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0145","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1083\/jcb.200705094","article-title":"A molecular mechanism directly linking E-cadherin adhesion to initiation of epithelial cell surface polarity","volume":"178","author":"Nejsum","year":"2007","journal-title":"J. Cell. Biol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0146","doi-asserted-by":"crossref","first-page":"13996","DOI":"10.1038\/ncomms13996","article-title":"Cell division orientation is coupled to cell-cell adhesion by the E-cadherin\/LGN complex","volume":"8","author":"Gloerich","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0147","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ceb.2012.07.006","article-title":"Cell adhesion in Drosophila: versatility of cadherin and integrin complexes during development","volume":"24","author":"Bulgakova","year":"2012","journal-title":"Curr. Opin. Cell. Biol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0148","doi-asserted-by":"crossref","first-page":"14813","DOI":"10.1073\/pnas.232389399","article-title":"DE-cadherin-mediated cell adhesion is essential for maintaining somatic stem cells in the Drosophila ovary","volume":"99","author":"Song","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0149","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0960-9822(01)00648-0","article-title":"Drosophila E-cadherin regulates the orientation of asymmetric cell division in the sensory organ lineage","volume":"12","author":"Le Borgne","year":"2002","journal-title":"Curr. Biol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0150","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1091\/mbc.e09-01-0023","article-title":"Cadherin adhesion receptors orient the mitotic spindle during symmetric cell division in mammalian epithelia","volume":"20","author":"den Elzen","year":"2009","journal-title":"Mol. Biol. Cell."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-018-0868-0","article-title":"Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma","volume":"22","author":"Mariette","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0152","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1158\/0008-5472.CAN-08-2457","article-title":"E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man","volume":"69","author":"Humar","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0153","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/jso.20958","article-title":"No mucosal escape of signet-ring cell carcinoma for ten years in a patient with familial aggregation of gastric cancer","volume":"97","author":"Tanis","year":"2008","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0154","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/sj.bjc.6605000","article-title":"Methodological approaches in application of synthetic lethality screening towards anticancer therapy","volume":"100","author":"Canaani","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0155","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0156","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","article-title":"Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase","volume":"434","author":"Bryant","year":"2005","journal-title":"Nature"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0157","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdz192","article-title":"A decade of clinical development of PARP inhibitors in perspective","volume":"30","author":"Mateo","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0158","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13045-020-00956-5","article-title":"Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation","volume":"13","author":"Topatana","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0159","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3389\/fonc.2019.01136","article-title":"Pan-cancer analysis of potential synthetic lethal drug targets specific to alterations in DNA damage response","volume":"9","author":"Das","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0160","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1186\/1471-2407-14-552","article-title":"E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition","volume":"14","author":"Chen","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0161","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1177\/1087057115605765","article-title":"A Comparison of Real-Time and Endpoint Cell Viability Assays for Improved Synthetic Lethal Drug Validation","author":"Single","year":"2015","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0162","doi-asserted-by":"crossref","first-page":"12511","DOI":"10.1038\/s41598-019-48929-0","article-title":"A high-throughput screen to identify novel synthetic lethal compounds for the treatment of E-cadherin-deficient cells","volume":"9","author":"Beetham","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0163","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3390\/cancers11091359","article-title":"Allosteric AKT inhibitors target synthetic lethal vulnerabilities in E-Cadherin-Deficient cells","volume":"11","author":"Bougen-Zhukov","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0164","first-page":"6075","article-title":"Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10","volume":"50","author":"Soule","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0165","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1046-2023(03)00032-X","article-title":"Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures","volume":"30","author":"Debnath","year":"2003","journal-title":"Methods"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0166","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10120-018-0859-1","article-title":"E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function","volume":"22","author":"Godwin","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0167","first-page":"2773","article-title":"Characteristics of cell lines established from human gastric carcinoma","volume":"50","author":"Park","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0168","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/1097-4644(20010501)81:2<241::AID-JCB1039>3.0.CO;2-B","article-title":"Gastric cancer cell lines as models to study human digestive functions","volume":"81","author":"Basque","year":"2001","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0169","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/jnci\/83.13.938","article-title":"Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines","volume":"83","author":"Kim","year":"1991","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0170","unstructured":"https:\/\/cellmodelpassports.sanger.ac.uk\/. (Accessed 12 May 2021)"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0171","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1158\/1535-7163.MCT-14-1092","article-title":"Synthetic lethal screens identify vulnerabilities in GPCR signaling and cytoskeletal organization in E-Cadherin-Deficient cells","volume":"14","author":"Telford","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0172","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1158\/2159-8290.CD-17-0603","article-title":"E-Cadherin\/ROS1 inhibitor synthetic lethality in breast cancer","volume":"8","author":"Bajrami","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0173","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1021\/ci300461a","article-title":"Broad coverage of commercially available lead-like screening space with fewer than 350,000 compounds","volume":"53","author":"Baell","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0174","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12967-017-1197-5","article-title":"Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer","volume":"15","author":"Chen","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0175","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40169-018-0184-7","article-title":"Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin-EGFR crosstalk","volume":"7","author":"Li","year":"2018","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0176","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/hmg\/ddm113","article-title":"EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells","volume":"16","author":"Mateus","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0177","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.yexcr.2009.02.020","article-title":"E-cadherin mutations and cell motility: a genotype-phenotype correlation","volume":"315","author":"Mateus","year":"2009","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0178","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1158\/0008-5472.CAN-07-1588","article-title":"Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations","volume":"68","author":"Bremm","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0179","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1038\/onc.2011.6","article-title":"E-cadherin inhibits tumor cell growth by suppressing PI3K\/Akt signaling via beta-catenin-Egr1-mediated PTEN expression","volume":"30","author":"Lau","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0180","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","article-title":"Human organoids: model systems for human biology and medicine","volume":"21","author":"Kim","year":"2020","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0181","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/gutjnl-2014-307949","article-title":"A novel human gastric primary cell culture system for modelling Helicobacter pylori infection in vitro","volume":"65","author":"Schlaermann","year":"2016","journal-title":"Gut"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0182","first-page":"149","article-title":"Gastric organoids: an emerging model system to study helicobacter pylori pathogenesis","volume":"400","author":"Pompaiah","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0183","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41418-020-00662-2","article-title":"Gastric organoids\u2014an in vitro model system for the study of gastric development and road to personalized medicine","volume":"28","author":"Seidlitz","year":"2021","journal-title":"Cell. Death Differ."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0184","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jcmgh.2018.09.008","article-title":"An organoid-based preclinical model of human gastric cancer","volume":"7","author":"Steele","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/gutjnl-2017-314549","article-title":"Human gastric cancer modelling using organoids","volume":"68","author":"Seidlitz","year":"2019","journal-title":"Gut"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0186","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5009\/gnl.2011.5.4.397","article-title":"The role of CD44 in the pathogenesis, diagnosis, and therapy of gastric cancer","volume":"5","author":"Jang","year":"2011","journal-title":"Gut Liver"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0187","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/1947601911428223","article-title":"CD44 promotes epithelial mammary gland development and exhibits altered localization during cancer progression","volume":"2","author":"Louderbough","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0188","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/stem.30","article-title":"Identification of gastric cancer stem cells using the cell surface marker CD44","volume":"27","author":"Takaishi","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0189","doi-asserted-by":"crossref","first-page":"16085","DOI":"10.1074\/jbc.M112.445551","article-title":"The hyaluronic acid receptor CD44 coordinates normal and metaplastic gastric epithelial progenitor cell proliferation","volume":"288","author":"Khurana","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0190","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ccell.2015.10.003","article-title":"Mist1 expressing gastric stem cells maintain the normal and neoplastic gastric epithelium and are supported by a perivascular stem cell niche","volume":"28","author":"Hayakawa","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0191","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1006\/dbio.1996.8454","article-title":"Mist1: a novel basic helix-loop-helix transcription factor exhibits a developmentally regulated expression pattern","volume":"182","author":"Lemercier","year":"1997","journal-title":"Dev. Biol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0192","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/(SICI)1097-0185(20000601)259:2<157::AID-AR6>3.0.CO;2-0","article-title":"Mist1 expression is a common link among serous exocrine cells exhibiting regulated exocytosis","volume":"259","author":"Pin","year":"2000","journal-title":"Anat. Rec."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0193","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.mod.2004.01.003","article-title":"Mist1 is necessary for the establishment of granule organization in serous exocrine cells of the gastrointestinal tract","volume":"121","author":"Johnson","year":"2004","journal-title":"Mech. Dev."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0194","doi-asserted-by":"crossref","first-page":"407","DOI":"10.21037\/jgo.2019.01.04","article-title":"Evaluation of confocal endoscopic microscopy for detection of early-stage gastric cancer in hereditary diffuse gastric cancer (HDGC) syndrome","volume":"10","author":"Ruff","year":"2019","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0195","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jnci\/88.11.699","article-title":"The search for cytotoxic synergy between anticancer agents: a case of Dorothy and the ruby slippers?","volume":"88","author":"Greco","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0196","doi-asserted-by":"crossref","first-page":"e00149","DOI":"10.1002\/prp2.149","article-title":"Analysis of drug combinations: current methodological landscape","volume":"3","author":"Foucquier","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/B978-0-323-85563-1.00011-3_bib0197","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Research and Clinical Applications of Targeting Gastric Neoplasms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323855631000113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323855631000113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T19:07:18Z","timestamp":1725476838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780323855631000113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780323855631"],"references-count":197,"URL":"https:\/\/doi.org\/10.1016\/b978-0-323-85563-1.00011-3","relation":{},"subject":[],"published":{"date-parts":[[2021]]}}}